ChemoMetec AS (OCSE:CHEMM) Non Operating Income: kr0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCSE:CHEMM ChemoMetec AS OCSE:CHEMM
99 GF Score
Price kr481.80
GF Value kr532.96
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is ChemoMetec AS Non Operating Income?

ChemoMetec AS OCSE:CHEMM +1.43% 99 Non Operating Income is kr0.0 Mil as of Dec. 2025. GuruFocus rates OCSE:CHEMM with a GF Score™ of 99/100 and a GF Value™ of kr532.96 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. ChemoMetec AS's Non Operating Income for the six months ended in Dec. 2025 was kr0.0 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was kr0.0 Mil.

ChemoMetec AS Non Operating Income Related Terms

ChemoMetec AS Non Operating Income Historical Data

* Premium members only.

The historical data trend for ChemoMetec AS's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ChemoMetec AS Non Operating Income Chart

ChemoMetec AS Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ChemoMetec AS Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OCSE:CHEMM
99GF Score
ChemoMetec AS OCSE:CHEMM
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ChemoMetec AS Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of kr0.0 Mil mean?
ChemoMetec AS (OCSE:CHEMM) has a Non Operating Income of kr0.0 Mil as of Dec. 2025. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on ChemoMetec AS and its competitors.
Is ChemoMetec AS's Non Operating Income too high?
ChemoMetec AS's current Non Operating Income is kr0.0 Mil. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's Non Operating Income compare to ABT and SYK?
ChemoMetec AS's Non Operating Income of kr0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Medical Devices & Instruments company?
A good Non Operating Income depends on the Medical Devices & Instruments industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on ChemoMetec AS and its competitors. ChemoMetec AS's current Non Operating Income is kr0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr532.96, compared to a current price of kr481.80 — trading 9.6% below its estimated fair value. The current Non Operating Income is kr0.0 Mil. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current Non Operating Income is kr0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?

Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued. The current stock price of kr481.80 is trading 9.6% below its estimated GF Value™ of kr532.96. GuruFocus considers ChemoMetec AS to be Modestly Undervalued.

Key valuation signals for OCSE:CHEMM:

  • Non Operating Income: kr0.0 Mil
  • GF Value™: kr532.96 vs. price of kr481.80 (9.6% below fair value)
  • GF Score™: 99/100 with 2 warning signs

No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ChemoMetec AS Business Description

Other Exchanges CHEMMc:UK0DZ0:UKCHY:Germany
Address Gydevang 43, Allerod, DNK, 3450
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score

Get the complete analysis for OCSE:CHEMM

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr481.80
Price
kr532.96
GF Value